GO
Loading...

Sequenom Inc

More

  • Big Drugmaker, Bigger Mistake Thursday, 29 Jan 2009 | 6:07 PM ET

    Since announcing a merger with Wyeth, drugmaker Pfizer has slipped 13%. So, how should trade healthcare?

  • Sequenom Put To The Test Thursday, 29 Jan 2009 | 1:43 PM ET
    Sequenom

    I need a break from blogging all-things Pfizer. Sequenom to the rescue with more data on its diagnostic test for Down Syndrome. Out of nearly 900 women there were no false negatives, but for the first time SQNM reported one false positive.

  • Making M&A Money in Big Pharma Friday, 23 Jan 2009 | 7:00 PM ET

    Who's next in the potential wave of consolidation set off by Pfizer and Wyeth? Cramer has an idea.

  • Four Hot Stocks in Four Diverse Sectors Thursday, 15 Jan 2009 | 11:47 AM ET

    Paul Noglows, director of research at Lazard Capital Markets, suggested four stock picks in four different sectors that will see growth over the year.

  • Speculating on Sequenom Friday, 19 Dec 2008 | 9:39 PM ET

    This company could revolutionize pregnancy testing, Cramer says, and make you a ton of money in the process.

  • Lightning Round OT: Apple, Immucor and More Monday, 10 Nov 2008 | 6:30 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

Most Popular Video

Tuesday, 22 Apr 2014 | 10:48 PM ET

Todd Elmer, Currency Strategist at Citi, discusses whether the currency's sharp drop following weaker-than-expected quarterly inflation data was justified.

Tuesday, 22 Apr 2014 | 10:30 PM ET

Adaire Fox-Martin, COO, Asia Pacific Japan at SAP, elaborates on the firm's "stunning results" in Southeast Asia, India and the sector of cloud computing in the first-quarter.

Tuesday, 22 Apr 2014 | 10:17 PM ET

Joe Magyer, Senior Analyst at The Motley Fool, says the flurry of activity on Wall Street looks "frothy" at the moment.